• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院癌症患者获得性长QT综合征——一项配对病例对照研究。

Hospitalized cancer patients with acquired long QT syndrome-a matched case-control study.

作者信息

Lin Yajuan, Yu Haixu, Liu Fei, Chen Cheng, Zhang Yanli, Wang Binhao, Yang Yiheng, Liu Ying, Zhang Li, Xia Yunlong

机构信息

1Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Zhongshan Road 222, PO Box 116011, Dalian, Liaoning China.

2Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.

出版信息

Cardiooncology. 2020 Feb 14;6:3. doi: 10.1186/s40959-020-0057-2. eCollection 2020.

DOI:10.1186/s40959-020-0057-2
PMID:32154029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7048064/
Abstract

BACKGROUND

Our recent study has revealed that many hospitalized patients with acquired long QT syndrome (ALQTS) are cancer patients. This study aims to determine the risk factors and outcomes of hospitalized cancer patients with ALQTS.

METHODS

We performed a matched case-control study within a cohort of 10,180 cancer patients hospitalized between September 2013 and April 2016. Among them, 150 patients defined as having severe ALQTS with a markedly prolonged QT interval (QTc ≥ 500 ms) were compared with 293 age-, sex- and cancer-type-matched controls (non-ALQTS). Death as the endpoint was followed for up to 2 years. Cox regression and Kaplan-Meier survival analyses were performed to assess the effects of particular clinical variables on all-cause mortality. Multivariate logistic regression was performed to calculate odds ratios (OR) for various predictors of QT prolongation.

RESULTS

The mortality was significantly higher in ALQTS group (63.3% vs. 33.4%). Hypertension, hypokalemia, hypocalcemia, QT-prolonging drugs, infection, anemia, anti-microtubule agents were contributing factors to ALQTS. Renal insufficiency, male gender and hypokalemia were found to be independent risk factors for all-cause mortality in ALQTS group.

CONCLUSION

Markedly prolonged QT interval was seen in 1.5% of hospitalized cancer patients. The all-cause mortality was high in cancer patients with severe ALQTS.

摘要

背景

我们最近的研究表明,许多获得性长QT综合征(ALQTS)住院患者是癌症患者。本研究旨在确定住院癌症合并ALQTS患者的危险因素及预后情况。

方法

我们在2013年9月至2016年4月期间住院的10180例癌症患者队列中进行了一项匹配病例对照研究。其中,150例被定义为患有严重ALQTS且QT间期显著延长(QTc≥500毫秒)的患者与293例年龄、性别和癌症类型匹配的对照者(非ALQTS)进行比较。以死亡为终点,随访长达2年。采用Cox回归和Kaplan-Meier生存分析来评估特定临床变量对全因死亡率的影响。进行多因素逻辑回归分析以计算QT延长各种预测因素的比值比(OR)。

结果

ALQTS组的死亡率显著更高(63.3%对33.4%)。高血压、低钾血症、低钙血症、延长QT的药物、感染、贫血、抗微管药物是导致ALQTS的因素。肾功能不全、男性和低钾血症被发现是ALQTS组全因死亡率的独立危险因素。

结论

1.5%的住院癌症患者出现QT间期显著延长。严重ALQTS的癌症患者全因死亡率很高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c1/7048064/e1dcd5b5d419/40959_2020_57_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c1/7048064/ff0c3abc3bc9/40959_2020_57_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c1/7048064/e1dcd5b5d419/40959_2020_57_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c1/7048064/ff0c3abc3bc9/40959_2020_57_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5c1/7048064/e1dcd5b5d419/40959_2020_57_Fig2_HTML.jpg

相似文献

1
Hospitalized cancer patients with acquired long QT syndrome-a matched case-control study.住院癌症患者获得性长QT综合征——一项配对病例对照研究。
Cardiooncology. 2020 Feb 14;6:3. doi: 10.1186/s40959-020-0057-2. eCollection 2020.
2
Acquired long QT syndrome in hospitalized patients.住院患者获得性长 QT 综合征。
Heart Rhythm. 2017 Jul;14(7):974-978. doi: 10.1016/j.hrthm.2017.03.014. Epub 2017 Mar 18.
3
Prevalence and risk factors for acquired long QT syndrome in the emergency department: a retrospective observational study.急诊科获得性长QT综合征的患病率及危险因素:一项回顾性观察研究。
World J Emerg Med. 2023;14(6):454-461. doi: 10.5847/wjem.j.1920-8642.2023.104.
4
The genetics underlying acquired long QT syndrome: impact for genetic screening.获得性长QT综合征的遗传学基础:对基因筛查的影响
Eur Heart J. 2016 May 7;37(18):1456-64. doi: 10.1093/eurheartj/ehv695. Epub 2015 Dec 28.
5
Prevalence and risk factors of acquired long QT syndrome in hospitalized patients with chronic kidney disease.住院慢性肾脏病患者获得性长 QT 综合征的患病率及危险因素。
J Investig Med. 2019 Feb;67(2):289-294. doi: 10.1136/jim-2018-000798. Epub 2018 Oct 26.
6
Identification of important risk factors for all-cause mortality of acquired long QT syndrome patients using random survival forests and non-negative matrix factorization.利用随机生存森林和非负矩阵分解鉴定获得性长 QT 综合征患者全因死亡率的重要危险因素。
Heart Rhythm. 2021 Mar;18(3):426-433. doi: 10.1016/j.hrthm.2020.10.022. Epub 2020 Oct 28.
7
Selective acquired long QT syndrome (saLQTS) upon risperidone treatment.利培酮治疗后选择性获得性长 QT 综合征(saLQTS)。
BMC Psychiatry. 2012 Dec 5;12:220. doi: 10.1186/1471-244X-12-220.
8
Post-acute management of the acquired long QT syndrome.获得性长QT综合征的急性后期管理。
Postgrad Med J. 2014 Jun;90(1064):348-58. doi: 10.1136/postgradmedj-2013-132398. Epub 2014 Apr 2.
9
Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.药物相关性尖端扭转型室速患者长QT综合征基因的等位基因变异。
Circulation. 2002 Apr 23;105(16):1943-8. doi: 10.1161/01.cir.0000014448.19052.4c.
10
Rare Variation in Drug Metabolism and Long QT Genes and the Genetic Susceptibility to Acquired Long QT Syndrome.药物代谢和长 QT 基因的罕见变异与获得性长 QT 综合征的遗传易感性。
Circ Genom Precis Med. 2022 Feb;15(1):e003391. doi: 10.1161/CIRCGEN.121.003391. Epub 2022 Feb 3.

引用本文的文献

1
Effect of Tucatinib on Cardiac Repolarization in Healthy Volunteers. Tucatinib 对健康志愿者心脏复极的影响。
Drugs R D. 2023 Dec;23(4):411-419. doi: 10.1007/s40268-023-00440-8. Epub 2023 Sep 26.
2
Metabolic and electrolyte abnormalities as risk factors in drug-induced long QT syndrome.代谢和电解质异常作为药物性长QT综合征的危险因素。
Biophys Rev. 2022 Jan 27;14(1):353-367. doi: 10.1007/s12551-022-00929-7. eCollection 2022 Feb.
3
Recurrent Pregnancy Loss and Concealed Long-QT Syndrome.复发性流产与隐匿性长QT综合征

本文引用的文献

1
Acquired long QT syndrome in hospitalized patients.住院患者获得性长 QT 综合征。
Heart Rhythm. 2017 Jul;14(7):974-978. doi: 10.1016/j.hrthm.2017.03.014. Epub 2017 Mar 18.
2
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).2016年欧洲心脏病学会(ESC)实践指南委员会主持制定的关于癌症治疗与心血管毒性的立场文件:欧洲心脏病学会(ESC)癌症治疗与心血管毒性特别工作组。
Eur Heart J. 2016 Sep 21;37(36):2768-2801. doi: 10.1093/eurheartj/ehw211. Epub 2016 Aug 26.
3
J Am Heart Assoc. 2021 Sep 7;10(17):e021236. doi: 10.1161/JAHA.121.021236. Epub 2021 Aug 16.
Does Anemia Cause QT Prolongation in Patients with Hematologic Disorders?
贫血会导致血液系统疾病患者QT间期延长吗?
Chin Med J (Engl). 2015 Dec 20;128(24):3385-6. doi: 10.4103/0366-6999.171468.
4
Cardiotoxicity of anticancer treatments.抗癌治疗的心脏毒性。
Nat Rev Cardiol. 2015 Nov;12(11):620. doi: 10.1038/nrcardio.2015.133. Epub 2015 Aug 20.
5
Cancer chemotherapy and cardiac arrhythmias: a review.癌症化疗与心律失常:综述
Drug Saf. 2015 Feb;38(2):129-52. doi: 10.1007/s40264-014-0258-4.
6
Overview and management of cardiac adverse events associated with tyrosine kinase inhibitors.酪氨酸激酶抑制剂相关心脏不良事件的概述与管理。
Oncologist. 2013;18(8):900-8. doi: 10.1634/theoncologist.2012-0466. Epub 2013 Aug 5.
7
Prolongation of QTc intervals and risk of death among patients with sickle cell disease.镰状细胞病患者 QTc 间期延长与死亡风险。
Eur J Haematol. 2013 Aug;91(2):170-8. doi: 10.1111/ejh.12127. Epub 2013 Jun 28.
8
Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on cardiac repolarisation (QT interval).酪氨酸激酶抑制剂的心血管安全性:特别关注心脏复极(QT 间期)。
Drug Saf. 2013 May;36(5):295-316. doi: 10.1007/s40264-013-0047-5.
9
Institution-wide QT alert system identifies patients with a high risk of mortality.全机构范围的 QT 警报系统识别出具有高死亡率风险的患者。
Mayo Clin Proc. 2013 Apr;88(4):315-25. doi: 10.1016/j.mayocp.2013.01.013.
10
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.欧洲癌症发病率和死亡率模式:2012 年 40 个国家的估计数。
Eur J Cancer. 2013 Apr;49(6):1374-403. doi: 10.1016/j.ejca.2012.12.027. Epub 2013 Feb 26.